Cancer Immunology, Immunotherapy

The role of B lymphocytes in the immuno-biology of non-small-cell lung cancer

• Open Access
• Review

Akshay J. Patel, Alex Richter, Mark T. Drayson, Gary W. Middleton

The effect of antibiotics on clinical outcomes in immune-checkpoint blockade: a systematic review and meta-analysis of observational studies

• Original Article

Brooke E. Wilson, Bertrand Routy, Adnan Nagrial, Venessa T. Chin

Immunogenic cell death by neoadjuvant oxaliplatin and radiation protects against metastatic failure in high-risk rectal cancer

• Open Access
• Original Article

Simer J. Bains, Hanna Abrahamsson, Kjersti Flatmark, Svein Dueland, Knut H. Hole, Therese Seierstad, Kathrine Røe Redalen, Sebastian Meltzer, Anne Hansen Ree

Immune checkpoint inhibitors combined with chemotherapy for the treatment of advanced pancreatic cancer patients

• Original Article

Junxun Ma, Danyang Sun, Jinliang Wang, Chun Han, Yuanyu Qian, Guangying Chen, Xiaoyan Li, Juan Zhang, Pengfei Cui, Wushuang Du, Zhaozhen Wu, Shixue Chen, Xuan Zheng, Zhichao Yue, Jia Song, Chan Gao, Shangli Cai, Yi Hu

Lung cancer-derived extracellular vesicles: a possible mediator of mast cell activation in the tumor microenvironment

• Original Article

Pazit Salamon, Yoseph A. Mekori, Irit Shefler

Translational immune correlates of indirect antibody immunization in a randomized phase II study using scheduled combination therapy with carboplatin/paclitaxel plus oregovomab in ovarian cancer patients

• Original Article

Alessandra Battaglia, Alexia Buzzonetti, Marco Fossati, Giovanni Scambia, Andrea Fattorossi, Madi R. Madiyalakan, Yolanda D. Mahnke, Christopher Nicodemus

Comparable outcomes of nivolumab in patients with advanced NSCLC presenting with or without brain metastases: a retrospective cohort study

• Original Article

Guowei Zhang, Ruirui Cheng, Huijuan Wang, Yong Zhang, Xiangtao Yan, Peng Li, Mina Zhang, Xiaojuan Zhang, Jinpo Yang, Yuanyuan Niu, Zhiyong Ma

Mass cytometry defines distinct immune profile in germinal center B-cell lymphomas

• Original Article

Mikael Roussel, Faustine Lhomme, Caroline E. Roe, Todd Bartkowiak, Pauline Gravelle, Camille Laurent, Thierry Fest, Jonathan M. Irish

The CD38low natural killer cell line KHYG1 transiently expressing CD16F158V in combination with daratumumab targets multiple myeloma cells with minimal effector NK cell fratricide

• Original Article

Subhashis Sarkar, Sachin K. S. Chauhan, John Daly, Alessandro Natoni, Heather Fairfield, Robert Henderson, Emma Nolan, Dawn Swan, Jinsong Hu, Michaela R. Reagan, Michael O’Dwyer

Clinical relevance of systemic monocytic-MDSCs in patients with metastatic breast cancer

• Open Access
• Original Article

Caroline Bergenfelz, Anna Roxå, Meliha Mehmeti, Karin Leandersson, Anna-Maria Larsson

Identification of two HLA-A*0201 immunogenic epitopes of lactate dehydrogenase C (LDHC): potential novel targets for cancer immunotherapy

• Open Access
• Original Article

Remy Thomas, Hibah Shaath, Adviti Naik, Salman M. Toor, Eyad Elkord, Julie Decock

The repertoire of tumor-infiltrating lymphocytes within the microenvironment of oral squamous cell carcinoma reveals immune dysfunction

• Original Article

Hongzhi Quan, Zhongyan Shan, Ziyi Liu, Sixuan Liu, Liu Yang, Xiaodan Fang, Kun Li, Baisheng Wang, Zhiyuan Deng, Yanjia Hu, Zhigang Yao, Junhui Huang, Jianjun Yu, Kun Xia, Zhangui Tang, Liangjuan Fang

Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial

• Open Access
• Clinical Trial Report

Steve Boudewijns, Martine Bloemendal, Nienke de Haas, Harm Westdorp, Kalijn F. Bol, Gerty Schreibelt, Erik H. J. G. Aarntzen, W. Joost Lesterhuis, Mark A. J. Gorris, Alexandra Croockewit, Lieke L. van der Woude, Michelle M. van Rossum, Marieke Welzen, Anna de Goede, Stanleyson V. Hato, Winette T. A. van der Graaf, Cornelis J. A. Punt, Rutger H. T. Koornstra, Winald R. Gerritsen, Carl G. Figdor, I. Jolanda M. de Vries

PD-L1 expression levels should be considered when identifying risk factors in NSCLC patients treated with nivolumab

• Letter to the Editors

Pengfei Li, Guowei Che

PCSK9 is a promising prognostic marker in patients with advanced NSCLC

• Letter to the Editors

Aldo Bonaventura, Francesco Grossi, Fabrizio Montecucco

Retraction Note to: Bio‑HMGB1 from breast cancer contributes to M‑MDSC differentiation from bone marrow progenitor cells and facilitates conversion of monocytes into MDSC‑like cells

• Retraction Note

Zhaoliang Su, Ping Ni, Peng She, Yueqin Liu, Seidu A. Richard, Wenlin Xu, Haitao Zhu, Jia Wang

Acknowledgement to reviewers

• Acknowledgement